Cargando…
Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
OBJECTIVE: To evaluate the associations between adiposity measures (body mass index, waist circumference, and waist-to-height ratio) with decline in glomerular filtration rate (GFR) and with all cause mortality. DESIGN: Individual participant data meta-analysis. SETTING: Cohorts from 40 countries wi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481269/ https://www.ncbi.nlm.nih.gov/pubmed/30630856 http://dx.doi.org/10.1136/bmj.k5301 |
_version_ | 1783413745918148608 |
---|---|
author | Chang, Alex R Grams, Morgan E Ballew, Shoshana H Bilo, Henk Correa, Adolfo Evans, Marie Gutierrez, Orlando M Hosseinpanah, Farhad Iseki, Kunitoshi Kenealy, Timothy Klein, Barbara Kronenberg, Florian Lee, Brian J Li, Yuanying Miura, Katsuyuki Navaneethan, Sankar D Roderick, Paul J Valdivielso, Jose M Visseren, Frank L J Zhang, Luxia Gansevoort, Ron T Hallan, Stein I Levey, Andrew S Matsushita, Kunihiro Shalev, Varda Woodward, Mark |
author_facet | Chang, Alex R Grams, Morgan E Ballew, Shoshana H Bilo, Henk Correa, Adolfo Evans, Marie Gutierrez, Orlando M Hosseinpanah, Farhad Iseki, Kunitoshi Kenealy, Timothy Klein, Barbara Kronenberg, Florian Lee, Brian J Li, Yuanying Miura, Katsuyuki Navaneethan, Sankar D Roderick, Paul J Valdivielso, Jose M Visseren, Frank L J Zhang, Luxia Gansevoort, Ron T Hallan, Stein I Levey, Andrew S Matsushita, Kunihiro Shalev, Varda Woodward, Mark |
author_sort | Chang, Alex R |
collection | PubMed |
description | OBJECTIVE: To evaluate the associations between adiposity measures (body mass index, waist circumference, and waist-to-height ratio) with decline in glomerular filtration rate (GFR) and with all cause mortality. DESIGN: Individual participant data meta-analysis. SETTING: Cohorts from 40 countries with data collected between 1970 and 2017. PARTICIPANTS: Adults in 39 general population cohorts (n=5 459 014), of which 21 (n=594 496) had data on waist circumference; six cohorts with high cardiovascular risk (n=84 417); and 18 cohorts with chronic kidney disease (n=91 607). MAIN OUTCOME MEASURES: GFR decline (estimated GFR decline ≥40%, initiation of kidney replacement therapy or estimated GFR <10 mL/min/1.73 m(2)) and all cause mortality. RESULTS: Over a mean follow-up of eight years, 246 607 (5.6%) individuals in the general population cohorts had GFR decline (18 118 (0.4%) end stage kidney disease events) and 782 329 (14.7%) died. Adjusting for age, sex, race, and current smoking, the hazard ratios for GFR decline comparing body mass indices 30, 35, and 40 with body mass index 25 were 1.18 (95% confidence interval 1.09 to 1.27), 1.69 (1.51 to 1.89), and 2.02 (1.80 to 2.27), respectively. Results were similar in all subgroups of estimated GFR. Associations weakened after adjustment for additional comorbidities, with respective hazard ratios of 1.03 (0.95 to 1.11), 1.28 (1.14 to 1.44), and 1.46 (1.28 to 1.67). The association between body mass index and death was J shaped, with the lowest risk at body mass index of 25. In the cohorts with high cardiovascular risk and chronic kidney disease (mean follow-up of six and four years, respectively), risk associations between higher body mass index and GFR decline were weaker than in the general population, and the association between body mass index and death was also J shaped, with the lowest risk between body mass index 25 and 30. In all cohort types, associations between higher waist circumference and higher waist-to-height ratio with GFR decline were similar to that of body mass index; however, increased risk of death was not associated with lower waist circumference or waist-to-height ratio, as was seen with body mass index. CONCLUSIONS: Elevated body mass index, waist circumference, and waist-to-height ratio are independent risk factors for GFR decline and death in individuals who have normal or reduced levels of estimated GFR. |
format | Online Article Text |
id | pubmed-6481269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64812692019-05-15 Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium Chang, Alex R Grams, Morgan E Ballew, Shoshana H Bilo, Henk Correa, Adolfo Evans, Marie Gutierrez, Orlando M Hosseinpanah, Farhad Iseki, Kunitoshi Kenealy, Timothy Klein, Barbara Kronenberg, Florian Lee, Brian J Li, Yuanying Miura, Katsuyuki Navaneethan, Sankar D Roderick, Paul J Valdivielso, Jose M Visseren, Frank L J Zhang, Luxia Gansevoort, Ron T Hallan, Stein I Levey, Andrew S Matsushita, Kunihiro Shalev, Varda Woodward, Mark BMJ Research OBJECTIVE: To evaluate the associations between adiposity measures (body mass index, waist circumference, and waist-to-height ratio) with decline in glomerular filtration rate (GFR) and with all cause mortality. DESIGN: Individual participant data meta-analysis. SETTING: Cohorts from 40 countries with data collected between 1970 and 2017. PARTICIPANTS: Adults in 39 general population cohorts (n=5 459 014), of which 21 (n=594 496) had data on waist circumference; six cohorts with high cardiovascular risk (n=84 417); and 18 cohorts with chronic kidney disease (n=91 607). MAIN OUTCOME MEASURES: GFR decline (estimated GFR decline ≥40%, initiation of kidney replacement therapy or estimated GFR <10 mL/min/1.73 m(2)) and all cause mortality. RESULTS: Over a mean follow-up of eight years, 246 607 (5.6%) individuals in the general population cohorts had GFR decline (18 118 (0.4%) end stage kidney disease events) and 782 329 (14.7%) died. Adjusting for age, sex, race, and current smoking, the hazard ratios for GFR decline comparing body mass indices 30, 35, and 40 with body mass index 25 were 1.18 (95% confidence interval 1.09 to 1.27), 1.69 (1.51 to 1.89), and 2.02 (1.80 to 2.27), respectively. Results were similar in all subgroups of estimated GFR. Associations weakened after adjustment for additional comorbidities, with respective hazard ratios of 1.03 (0.95 to 1.11), 1.28 (1.14 to 1.44), and 1.46 (1.28 to 1.67). The association between body mass index and death was J shaped, with the lowest risk at body mass index of 25. In the cohorts with high cardiovascular risk and chronic kidney disease (mean follow-up of six and four years, respectively), risk associations between higher body mass index and GFR decline were weaker than in the general population, and the association between body mass index and death was also J shaped, with the lowest risk between body mass index 25 and 30. In all cohort types, associations between higher waist circumference and higher waist-to-height ratio with GFR decline were similar to that of body mass index; however, increased risk of death was not associated with lower waist circumference or waist-to-height ratio, as was seen with body mass index. CONCLUSIONS: Elevated body mass index, waist circumference, and waist-to-height ratio are independent risk factors for GFR decline and death in individuals who have normal or reduced levels of estimated GFR. BMJ Publishing Group Ltd. 2019-01-10 /pmc/articles/PMC6481269/ /pubmed/30630856 http://dx.doi.org/10.1136/bmj.k5301 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Chang, Alex R Grams, Morgan E Ballew, Shoshana H Bilo, Henk Correa, Adolfo Evans, Marie Gutierrez, Orlando M Hosseinpanah, Farhad Iseki, Kunitoshi Kenealy, Timothy Klein, Barbara Kronenberg, Florian Lee, Brian J Li, Yuanying Miura, Katsuyuki Navaneethan, Sankar D Roderick, Paul J Valdivielso, Jose M Visseren, Frank L J Zhang, Luxia Gansevoort, Ron T Hallan, Stein I Levey, Andrew S Matsushita, Kunihiro Shalev, Varda Woodward, Mark Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
title | Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
title_full | Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
title_fullStr | Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
title_full_unstemmed | Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
title_short | Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
title_sort | adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481269/ https://www.ncbi.nlm.nih.gov/pubmed/30630856 http://dx.doi.org/10.1136/bmj.k5301 |
work_keys_str_mv | AT changalexr adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT gramsmorgane adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT ballewshoshanah adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT bilohenk adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT correaadolfo adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT evansmarie adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT gutierrezorlandom adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT hosseinpanahfarhad adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT isekikunitoshi adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT kenealytimothy adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT kleinbarbara adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT kronenbergflorian adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT leebrianj adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT liyuanying adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT miurakatsuyuki adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT navaneethansankard adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT roderickpaulj adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT valdivielsojosem adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT visserenfranklj adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT zhangluxia adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT gansevoortront adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT hallansteini adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT leveyandrews adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT matsushitakunihiro adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT shalevvarda adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium AT woodwardmark adiposityandriskofdeclineinglomerularfiltrationratemetaanalysisofindividualparticipantdatainaglobalconsortium |